Search Prime Grants

W81XWH2210745

Project Grant

Overview

Grant Description
Inhibition of scarring fibrosis and neovascularization after corneal injury.
Awardee
The Cleveland Clinic Foundation
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Cleveland, Ohio 441950001 United States
Geographic Scope
Single Zip Code
Related Opportunity
None
Analysis Notes
Amendment Since initial award the total obligations have decreased 100% from $1,173,369 to $0.
The Cleveland Clinic Foundation was awarded Project Grant W81XWH2210745 from Defense Health Agency in September 2022 with work to be completed primarily in Cleveland Ohio United States. The grant has a duration of 3 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 8/8/23

Period of Performance
9/30/22
Start Date
9/29/25
End Date
52.0% Complete

Funding Split
$0.0
Federal Obligation
$0.0
Non-Federal Obligation
$0.0
Total Obligated
100% Federal Funding
0% Non-Federal Funding

Transaction History

Modifications to W81XWH2210745

Additional Detail

Award ID FAIN
W81XWH2210745
SAI Number
None
Award ID URI
None
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Other
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
TDGUJ1WA4UJ9
Awardee CAGE
1PZL9
Performance District
OH-11
Senators
Sherrod Brown
J.D. (James) Vance

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Defense Health Program, Defense (097-0130) Department of Defense-Military Grants, subsidies, and contributions (41.0) $1,173,369 100%
Modified: 8/8/23